vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and PEOPLES FINANCIAL SERVICES CORP. (PFIS). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $46.8M, roughly 1.3× PEOPLES FINANCIAL SERVICES CORP.). PEOPLES FINANCIAL SERVICES CORP. runs the higher net margin — 27.8% vs -70.9%, a 98.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 5.8%). PEOPLES FINANCIAL SERVICES CORP. produced more free cash flow last quarter ($43.3M vs $-1.8M). Over the past eight quarters, PEOPLES FINANCIAL SERVICES CORP.'s revenue compounded faster (43.5% CAGR vs 17.7%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

CTKB vs PFIS — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.3× larger
CTKB
$62.1M
$46.8M
PFIS
Growing faster (revenue YoY)
CTKB
CTKB
+2.3% gap
CTKB
8.1%
5.8%
PFIS
Higher net margin
PFIS
PFIS
98.8% more per $
PFIS
27.8%
-70.9%
CTKB
More free cash flow
PFIS
PFIS
$45.1M more FCF
PFIS
$43.3M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
PFIS
PFIS
Annualised
PFIS
43.5%
17.7%
CTKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
PFIS
PFIS
Revenue
$62.1M
$46.8M
Net Profit
$-44.1M
$12.0M
Gross Margin
52.9%
Operating Margin
-9.0%
31.5%
Net Margin
-70.9%
27.8%
Revenue YoY
8.1%
5.8%
Net Profit YoY
-557.1%
96.7%
EPS (diluted)
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
PFIS
PFIS
Q4 25
$62.1M
$46.8M
Q3 25
$52.3M
$46.7M
Q2 25
$45.6M
$48.4M
Q1 25
$41.5M
$45.8M
Q4 24
$57.5M
$44.2M
Q3 24
$51.5M
$45.0M
Q2 24
$46.6M
$22.5M
Q1 24
$44.9M
$22.7M
Net Profit
CTKB
CTKB
PFIS
PFIS
Q4 25
$-44.1M
$12.0M
Q3 25
$-5.5M
$15.2M
Q2 25
$-5.6M
$17.0M
Q1 25
$-11.4M
$15.0M
Q4 24
$9.6M
$6.1M
Q3 24
$941.0K
$-4.3M
Q2 24
$-10.4M
$3.3M
Q1 24
$-6.2M
$3.5M
Gross Margin
CTKB
CTKB
PFIS
PFIS
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
PFIS
PFIS
Q4 25
-9.0%
31.5%
Q3 25
-17.6%
40.4%
Q2 25
-23.3%
42.2%
Q1 25
-36.1%
39.8%
Q4 24
5.2%
13.2%
Q3 24
-8.2%
-11.1%
Q2 24
-18.3%
16.5%
Q1 24
-23.9%
17.4%
Net Margin
CTKB
CTKB
PFIS
PFIS
Q4 25
-70.9%
27.8%
Q3 25
-10.5%
32.7%
Q2 25
-12.2%
35.0%
Q1 25
-27.5%
32.8%
Q4 24
16.8%
15.8%
Q3 24
1.8%
-9.6%
Q2 24
-22.4%
14.6%
Q1 24
-13.8%
15.3%
EPS (diluted)
CTKB
CTKB
PFIS
PFIS
Q4 25
$1.20
Q3 25
$1.51
Q2 25
$1.68
Q1 25
$1.49
Q4 24
$0.47
Q3 24
$-0.43
Q2 24
$0.46
Q1 24
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
PFIS
PFIS
Cash + ST InvestmentsLiquidity on hand
$90.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$519.8M
Total Assets
$461.5M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
PFIS
PFIS
Q4 25
$90.9M
Q3 25
$93.3M
Q2 25
$75.5M
Q1 25
$95.3M
Q4 24
$98.7M
Q3 24
$162.3M
Q2 24
$177.9M
Q1 24
$168.8M
Stockholders' Equity
CTKB
CTKB
PFIS
PFIS
Q4 25
$341.7M
$519.8M
Q3 25
$378.6M
$509.3M
Q2 25
$377.6M
$494.1M
Q1 25
$379.6M
$481.9M
Q4 24
$395.7M
$468.9M
Q3 24
$385.5M
$475.1M
Q2 24
$389.1M
$340.8M
Q1 24
$392.6M
$340.0M
Total Assets
CTKB
CTKB
PFIS
PFIS
Q4 25
$461.5M
$5.3B
Q3 25
$494.9M
$5.2B
Q2 25
$493.3M
$5.1B
Q1 25
$482.6M
$5.0B
Q4 24
$499.5M
$5.1B
Q3 24
$491.2M
$5.4B
Q2 24
$483.7M
$3.6B
Q1 24
$492.1M
$3.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
PFIS
PFIS
Operating Cash FlowLast quarter
$-771.0K
$54.3M
Free Cash FlowOCF − Capex
$-1.8M
$43.3M
FCF MarginFCF / Revenue
-2.9%
92.7%
Capex IntensityCapex / Revenue
1.6%
23.4%
Cash ConversionOCF / Net Profit
4.53×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$73.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
PFIS
PFIS
Q4 25
$-771.0K
$54.3M
Q3 25
$-3.9M
$15.2M
Q2 25
$108.0K
$13.9M
Q1 25
$-125.0K
$9.1M
Q4 24
$2.0M
$34.7M
Q3 24
$13.2M
$21.9M
Q2 24
$6.2M
$1.7M
Q1 24
$4.0M
$3.2M
Free Cash Flow
CTKB
CTKB
PFIS
PFIS
Q4 25
$-1.8M
$43.3M
Q3 25
$-4.6M
$13.0M
Q2 25
$-1.5M
$8.5M
Q1 25
$-974.0K
$8.6M
Q4 24
$1.1M
$32.1M
Q3 24
$12.2M
$17.6M
Q2 24
$5.2M
$1.3M
Q1 24
$3.4M
$3.0M
FCF Margin
CTKB
CTKB
PFIS
PFIS
Q4 25
-2.9%
92.7%
Q3 25
-8.7%
27.9%
Q2 25
-3.2%
17.6%
Q1 25
-2.3%
18.7%
Q4 24
1.9%
72.8%
Q3 24
23.7%
39.1%
Q2 24
11.0%
6.0%
Q1 24
7.6%
13.3%
Capex Intensity
CTKB
CTKB
PFIS
PFIS
Q4 25
1.6%
23.4%
Q3 25
1.3%
4.7%
Q2 25
3.5%
11.1%
Q1 25
2.0%
1.1%
Q4 24
1.6%
5.8%
Q3 24
2.0%
9.6%
Q2 24
2.3%
1.8%
Q1 24
1.3%
1.0%
Cash Conversion
CTKB
CTKB
PFIS
PFIS
Q4 25
4.53×
Q3 25
1.00×
Q2 25
0.82×
Q1 25
0.60×
Q4 24
0.21×
5.70×
Q3 24
14.05×
Q2 24
0.53×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

PFIS
PFIS

Segment breakdown not available.

Related Comparisons